Cargando…
Preclinical and clinical development of the anti-HIV, anti-HBV oxathiolane nucleoside analog emtricitabine
Three classes of drugs are available to treat patients infected with human immunodeficiency virus (HIV) : the nucleoside reverse transcriptase inhibitors (NRTI), the nonnucleoside reverse transcriptase inhibitors (NNRTI), and the protease inhibitors (PI). Emtricitabine represents one of the most pot...
Autores principales: | Painter, George R., Rimsky, Laurence T., Furman, Phillip A., Liotta, Dennis C., Schinazi, Raymond F., Quinn, Joseph B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7155727/ http://dx.doi.org/10.1016/B978-044450986-4/50088-6 |
Ejemplares similares
-
Synthetic strategies toward 1,3-oxathiolane nucleoside analogues
por: Aher, Umesh P, et al.
Publicado: (2021) -
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2
por: Feng, Joy Y., et al.
Publicado: (2022) -
Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020) -
Synthesis of an Oxathiolane Drug Substance Intermediate
Guided by Constraint-Driven Innovation
por: Kashinath, K., et al.
Publicado: (2020) -
Diverse models for anti-HIV activity of purine nucleoside analogs
por: Khatri, Naveen, et al.
Publicado: (2015)